Total Payments
$7,663
2024 Payments
$967.38
Companies
29
Transactions
365
Medicare Patients
1,931
Medicare Billing
$99,101
Payment Breakdown by Category
Food & Beverage$7,210 (94.1%)
Education$453.70 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,210 | 360 | 94.1% |
| Education | $453.70 | 5 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,240 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $662.66 | 21 | $0 (2024) |
| Dermavant Sciences, Inc. | $588.47 | 34 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $567.28 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $542.86 | 32 | $0 (2024) |
| Galderma Laboratories, L.P. | $515.85 | 18 | $0 (2024) |
| Lilly USA, LLC | $450.67 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $332.63 | 14 | $0 (2024) |
| Amgen Inc. | $299.44 | 12 | $0 (2024) |
| MAYNE PHARMA INC. | $292.69 | 38 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $967.38 | 44 | E.R. Squibb & Sons, L.L.C. ($215.64) |
| 2023 | $2,459 | 93 | ABBVIE INC. ($479.66) |
| 2022 | $2,132 | 123 | ABBVIE INC. ($381.66) |
| 2021 | $2,105 | 105 | Galderma Laboratories, L.P. ($334.07) |
All Payment Transactions
365 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Immunology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.28 | General |
| Category: Immunology | ||||||
| 10/09/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 08/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: DERMATOLOGY | ||||||
| 08/07/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Immunology | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 06/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Inflammation | ||||||
| 05/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Dermatology | ||||||
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Dermatology | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Dermatology | ||||||
| 03/26/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 03/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: DERMATOLOGY | ||||||
| 03/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $120.64 | General |
| Category: DERMATOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 769 | 1,039 | $126,817 | $39,824 |
| 2022 | 9 | 614 | 898 | $104,632 | $35,426 |
| 2021 | 7 | 264 | 300 | $40,820 | $11,786 |
| 2020 | 7 | 284 | 342 | $44,376 | $12,065 |
Total Patients
1,931
Total Services
2,579
Medicare Billing
$99,101
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 317 | $45,952 | $14,922 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 125 | $25,843 | $8,619 | 33.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 84 | $15,496 | $4,852 | 31.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 95 | 97 | $15,796 | $4,660 | 29.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 99 | 109 | $12,315 | $3,308 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $3,612 | $1,011 | 28.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 60 | 202 | $2,702 | $800.18 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,633 | $621.92 | 38.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 21 | $1,740 | $553.74 | 31.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 17 | $1,606 | $453.49 | 28.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 29 | $122.00 | $21.87 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 231 | $33,559 | $12,048 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 126 | $26,315 | $8,803 | 33.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 80 | 86 | $14,240 | $4,851 | 34.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 56 | 62 | $11,650 | $4,174 | 35.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 81 | 93 | $11,090 | $3,146 | 28.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 24 | 37 | $3,139 | $1,206 | 38.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 57 | 137 | $2,677 | $592.61 | 22.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 11 | 19 | $1,767 | $528.88 | 29.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 107 | $195.00 | $75.88 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 68 | $9,613 | $3,312 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 38 | $7,997 | $2,743 | 34.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 30 | 31 | $4,954 | $1,737 | 35.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 32 | 32 | $6,180 | $1,467 | 23.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 43 | 51 | $6,934 | $1,412 | 20.4% |
About Stephanie Lee
Stephanie Lee is a Nurse Practitioner healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2015. The National Provider Identifier (NPI) number assigned to this provider is 1437547288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Lee has received a total of $7,663 in payments from pharmaceutical and medical device companies, with $967.38 received in 2024. These payments were reported across 365 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,210).
As a Medicare-enrolled provider, Lee has provided services to 1,931 Medicare beneficiaries, totaling 2,579 services with total Medicare billing of $99,101. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Overland Park, KS
- Active Since 01/02/2015
- Last Updated 01/02/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1437547288
Products in Payments
- RINVOQ (Biological) $695.69
- VTAMA (Drug) $588.47
- Sotyktu (Drug) $553.09
- TREMFYA (Drug) $509.94
- DUPIXENT (Biological) $427.06
- TALTZ (Drug) $340.45
- SKYRIZI (Biological) $307.79
- AKLIEF (Drug) $284.65
- OPZELURA (Drug) $281.17
- Otezla (Drug) $278.05
- HUMIRA (Biological) $211.92
- BLU-U (Medical Supply) $184.84
- COSENTYX (Drug) $170.25
- Seysara (Drug) $159.41
- REMICADE (Biological) $152.72
- EPSOLAY (Drug) $147.47
- Puraply (Medical Supply) $138.83
- EUCRISA (Drug) $129.26
- ADBRY (Biological) $126.12
- Ilumya (Biological) $111.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Overland Park
Mrs. Brenda Lane, Arnp, ARNP
Nurse Practitioner — Payments: $10,253
Nurse Practitioner $10,253
Katelyn Freeman, Np, NP
Nurse Practitioner — Payments: $8,210
Nurse Practitioner $8,210
Kimberly Nagel, Arnp, ARNP
Nurse Practitioner — Payments: $4,659
Nurse Practitioner $4,659
Jennifer Searcy, Np, NP
Nurse Practitioner — Payments: $4,383
Nurse Practitioner $4,383
Patience Mccoy, Acnp-Bc, ACNP-BC
Nurse Practitioner — Payments: $4,097
Nurse Practitioner $4,097
Hannah Jenkins, Arpn, Fnp-C, ARPN, FNP-C
Nurse Practitioner — Payments: $3,967
Nurse Practitioner $3,967